nifekalant hydrochloride has been researched along with monocrotaline in 1 studies
| Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (monocrotaline) | Trials (monocrotaline) | Recent Studies (post-2010) (monocrotaline) |
|---|---|---|---|---|---|
| 138 | 16 | 38 | 1,746 | 3 | 850 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, H; Hirose, M; Kagaya, Y; Miura, M; Nakano, M; Shimokawa, H; Shirato, K; Sugai, Y; Takahashi, J; Wakayama, Y; Watanabe, J | 1 |
1 other study(ies) available for nifekalant hydrochloride and monocrotaline
| Article | Year |
|---|---|
Reduced inotropic effect of nifekalant in failing hearts in rats.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Disease Models, Animal; Heart Failure; Monocrotaline; Myocardial Contraction; Pyrimidinones; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 2006 |